Join us now
The Calcitonin Gene-Related Peptide (CGRP) Forum has been established by an international group of clinicians and researchers. It provides all healthcare professionals with open and free access to independent news, information, comment and resources about the exciting potential of CGRP as a novel therapeutic target for the prevention of migraine in millions of people worldwide.
View invitations from the editorsBecome a member of CGRP Forum now
Real World Experience
Find out how other clinicians are using anti-CGRP therapies in their daily practice. Catch up with the latest real world data and share your experiences with colleagues around the world.Read more
Is anti-CGRP therapy approved for your patients?
Check back regularly at our expert guide to see the regulatory status and approved indications for anti-CGRP therapies worldwide.Read More
Meet the Expert
In a unique series of educational videos, leading migraine specialists from around the world discuss the current state of migraine care where they practise and advise on latest developments in diagnosis and treatment.Read More
Members get free, open access - Register now »
From the EditorsOur distinguished Editors discuss the latest developments and provide their views:Will CGRP antibodies put an end to migraine?View all articles
Latest NewsView all News
Hot TopicsView all Hot Topics
TrialsEasy-to-access digests of all the key trials completed & ongoing:Eptinezumab (ALD403)Erenumab (AMG 334)Galcanezumab (LY2951742)Fremanezumab (TEV-48125)View all Trials
Meeting ReportsHighlights from the latest meetings:
75th American Academy of Neurology Annual Meeting 2023 16th European Headache Congress Migraine Trust International Symposium 2022 View all Meeting Reports